Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

21 July 2022: Clinical Research

Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization

Jun Li BCDE , Jing Wang ABCEF*

DOI: 10.12659/MSM.935326

Med Sci Monit 2022; 28:e935326

Figure 6 Dynamic changes in serum Tim-3 during the peri-TACE period predicted poor prognosis. (A) Kaplan-Meier curve analysis for progression, in the training set, when patients were stratified according to their peri-TACE period serum Tim-3 levels. (B) Kaplan-Meier curve analysis for death, in the training set, when patients were stratified according to their peri-TACE period serum Tim-3 levels. Kaplan-Meier analyses were conducted and log-rank tests were performed. TACE – transcatheter arterial chemoembolization; Tim-3 – T cell immunoglobulin and mucin domain 3.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750